Materials and Methods: In the present study, two advanced prostate-cancer patients took o-rMETase as a supplement for approximately one month. Results: One of the patients taking o-rMETase showed a 38% reduction of PSA levels and the second patient showed a 20% PSA reduction. Conclusion: ...
Advanced prostate cancer may require advanced treatment options. What is PSA? Prostate-specific antigen (PSA) is a protein made by the prostate. In healthy men, some PSA is found in the blood. If PSA levels in the blood are higher than normal, it may signal a problem in the prostate. ...
ADT indicates androgen-deprivation therapy; CRPC, castration-resistant prostate cancer; FDA, US Food and Drug Administration; LHRH, luteinizing hormone-releasing hormone; PCa, prostate cancer; PSA, prostate-specific antigen. Source: Adapted with permission from Crawford ED, Flaig TW. Optimizing outcomes...
LUPRON DEPOT (leuprolide acetate for depot suspension) has helped treat advanced prostate cancer for over 35 years. Find out if treatment is right for you.
than castration on serum prostate specific antigen (PSA) levels. Combining bicalutamide in this dosage with a GnRH agonist, or increasing the dosage to 150 mg/day as monotherapy, reduces serum PSA levels further than bicalutamide 50 mg/day and to a similar extent to flutamide plus a GnRH ...
PSA levels, in the context of prostate cancer, refer to the level of prostate-specific antigen (PSA) in the blood, the marker which is secreted by the prostate and is elevated by cancer. Among the 43 men whose PSA results were available three months after SBRT and whose cancer didn't pr...
own was not considered equivalent to advanced prostate cancer and was not extracted, as the definition of “high-grade” has been inconsistent over time, incorporating Gleason scores (the definition of which has changed over time [13]), tumor, node, metastases [TNM] scores, and PSA levels. ...
PSA is a protein produced by the prostate gland and is commonly used as a biomarker to diagnose and follow prostate cancer. A ≥ 50% reduction in PSA levels from baseline is considered clinically relevant and has been shown to corre...
In the treatment of advanced prostate cancer Drop Testosterone Fast Patients on FIRMAGON® reached their treatment goal in 3 days1 The goal of hormone therapy is to lower Testosterone (T) levels. With FIRMAGON, you don't have to wait. PSA reduction usually follows T drop.2 In a clinical ...
Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes. INTRODUCTION: Radical prostatectomy (RP) in patients with high-risk prostate cancer (PC) [prostate specific antigen (PSA) 鈮 20 ng/mL, and/or Gleason score ... Mearini,...